Carregant...
Clinical use of Jak 1 inhibitors for rheumatoid arthritis
The uptake of Jak inhibitors in the RA space has been among the most rapid in rheumatology, based on the results of comprehensive clinical trial programmes of five agents. Newer generations of Jak inhibitors, like upadacitinib and filgotinib, target Jak 1 selectively with the aim of maximizing effic...
Guardat en:
| Publicat a: | Rheumatology (Oxford) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098107/ https://ncbi.nlm.nih.gov/pubmed/33950231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keab265 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|